Literature DB >> 1639486

Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein.

P Van Der Ley1, J T Poolman.   

Abstract

Outer membrane complexes (OMCs) are promising vaccine candidates for protection against meningococcal disease. However, a major obstacle to this approach is the fact that the protective antibodies induced are generally type specific. In an attempt to overcome this problem, we have investigated the possibility of constructing a multivalent vaccine strain by insertion of an additional class 1 outer membrane protein-encoding gene. Starting with a derivative of strain H44/76 deficient in class 3 outer membrane protein, a second class 1 gene was inserted into the chromosome, through homologous recombination with a suicide plasmid carrying the class 1 gene from strain 2996 placed within a class 5 gene. In this way, a strain was obtained in which a class 3 protein was in effect replaced by a class 1 protein from another subtype, i.e. P1.5,2 in addition to the P1.7,16 protein of H44/76. Immunization of mice with such OMCs resulted in high bactericidal titers against both H44/76 and 2996, where normally only strain-specific antibodies are induced. Mutational removal of class 3 protein from the immunizing OMCs had no detectable effect on the bactericidal titer against H44/76, whereas removal of class 1 protein led to a strong reduction. These results demonstrate the dominant role of the subtype-specific sequences of class 1 protein in the induction of bactericidal antibodies and show that construction of a multivalent OMC-based vaccine should be feasible.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639486      PMCID: PMC257296          DOI: 10.1128/iai.60.8.3156-3161.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Topology of outer membrane porins in pathogenic Neisseria spp.

Authors:  P van der Ley; J E Heckels; M Virji; P Hoogerhout; J T Poolman
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

2.  Characterization of the opa (class 5) gene family of Neisseria meningitidis.

Authors:  E L Aho; J A Dempsey; M M Hobbs; D G Klapper; J G Cannon
Journal:  Mol Microbiol       Date:  1991-06       Impact factor: 3.501

Review 3.  Chimeric single-stranded DNA phage-plasmid cloning vectors.

Authors:  D A Mead; B Kemper
Journal:  Biotechnology       Date:  1988

4.  Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole-cell ELISA.

Authors:  H Abdillahi; J T Poolman
Journal:  Microb Pathog       Date:  1988-01       Impact factor: 3.738

5.  Three copies of a single protein II-encoding sequence in the genome of Neisseria gonorrhoeae JS3: evidence for gene conversion and gene duplication.

Authors:  P van der Ley
Journal:  Mol Microbiol       Date:  1988-11       Impact factor: 3.501

6.  Human immunoglobulin G subclass immune response to outer membrane antigens in meningococcal group B vaccine.

Authors:  E Wedege; T E Michaelsen
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

7.  Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting.

Authors:  E Wedege; L O Frøholm
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

8.  Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay.

Authors:  K Saukkonen; M Leinonen; H Abdillahi; J T Poolman
Journal:  Vaccine       Date:  1989-08       Impact factor: 3.641

9.  Antibody responses to serogroup B meningococcal outer membrane antigens after vaccination and infection.

Authors:  E Rosenqvist; S Harthug; L O Frøholm; E A Høiby; K Bøvre; W D Zollinger
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

10.  Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development.

Authors:  K Saukkonen; H Abdillahi; J T Poolman; M Leinonen
Journal:  Microb Pathog       Date:  1987-10       Impact factor: 3.738

View more
  34 in total

1.  Mu-like Prophage in serogroup B Neisseria meningitidis coding for surface-exposed antigens.

Authors:  V Masignani; M M Giuliani; H Tettelin; M Comanducci; R Rappuoli; V Scarlato
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Outer membrane composition of a lipopolysaccharide-deficient Neisseria meningitidis mutant.

Authors:  L Steeghs; H de Cock; E Evers; B Zomer; J Tommassen; P van der Ley
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

3.  Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB.

Authors:  A K Lehmann; A Halstensen; I S Aaberge; J Holst; T E Michaelsen; S Sornes; L M Wetzler; H Guttormsen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

4.  Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.

Authors:  E R van der Voort; P van der Ley; J van der Biezen; S George; O Tunnela; H van Dijken; B Kuipers; J Poolman
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Working mechanism of immunoglobulin A1 (IgA1) protease: cleavage of IgA1 antibody to Neisseria meningitidis PorA requires de novo synthesis of IgA1 Protease.

Authors:  Gestur Vidarsson; Natasja Overbeeke; Annette M Stemerding; Germie van den Dobbelsteen; Peter van Ulsen; Peter van der Ley; Mogens Kilian; Jan G J van de Winkel
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Rapid genetic grouping of factor h-binding protein (genome-derived neisserial antigen 1870), a promising group B meningococcal vaccine candidate.

Authors:  Peter T Beernink; Arunas Leipus; Dan M Granoff
Journal:  Clin Vaccine Immunol       Date:  2006-07

7.  Two-partner secretion systems of Neisseria meningitidis associated with invasive clonal complexes.

Authors:  Peter van Ulsen; Lucy Rutten; Moniek Feller; Jan Tommassen; Arie van der Ende
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

8.  Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.

Authors:  P van der Ley; J van der Biezen; P Hohenstein; C Peeters; J T Poolman
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

9.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands.

Authors:  Stefania Bambini; Jurgen Piet; Alessandro Muzzi; Wendy Keijzers; Sara Comandi; Lisa De Tora; Mariagrazia Pizza; Rino Rappuoli; Diederik van de Beek; Arie van der Ende; Maurizio Comanducci
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.